about
A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinomaIntegration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis.Circulating proteolytic products of carboxypeptidase N for early detection of breast cancerMS/MS library facilitated MRM quantification of native peptides prepared by denaturing ultrafiltration.Mass spectrometry-based proteomics: existing capabilities and future directionsHuman endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis.Mechanistic peptidomics: factors that dictate specificity in the formation of endogenous peptides in human milk.Comprehensive quantitative analysis of ovarian and breast cancer tumor peptidomes.Effectiveness of CID, HCD, and ETD with FT MS/MS for degradomic-peptidomic analysis: comparison of peptide identification methods.Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques.Clinical predictive circulating peptides in rectal cancer patients treated with neoadjuvant chemoradiotherapy.Improving collision induced dissociation (CID), high energy collision dissociation (HCD), and electron transfer dissociation (ETD) fourier transform MS/MS degradome-peptidome identifications using high accuracy mass informationThe Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM SensitivityPrediction of Toxin Genes from Chinese Yellow Catfish Based on Transcriptomic and Proteomic Sequencing.Quantitation of endogenous peptides using mass spectrometry based methods.Intact Cell MALDI-TOF MS on Sperm: A Molecular Test For Male Fertility Diagnosis.Identification and function of proteolysis regulators in seminal fluid.Novel Bioinformatics-Based Approach for Proteomic Biomarkers Prediction of Calpain-2 &Caspase-3 Protease Fragmentation: Application to βII-Spectrin ProteinThe lymph self-antigen repertoire.Lymph formation, composition and circulation: a proteomics perspective.Clinical implications of recent advances in proteogenomics.
P2860
Q28741189-F7B75C3F-81DD-4965-A0CA-C2A2D72788C9Q31111254-133591B4-F131-4C37-8C95-98D781556A1AQ33685829-9D232219-F93B-47BD-A6B1-26027CC86826Q34150493-18F383E1-764C-4610-B887-85C16A8FD97FQ34267972-C65AC845-AEC9-406E-9626-A260C186C5BAQ34315003-8876499D-B275-474D-8E22-DD33EE3280AEQ34542887-976C187C-0302-43D8-90F2-905EEBE0D806Q34634913-E42DD7CA-37C1-47BC-9334-70C7DD9C7A86Q34855337-86E2681B-7060-4F5E-B9E2-35FCB0EE6CE1Q35194518-51E9B1BC-2068-4890-9147-55D4D52CBB00Q35266857-759437FB-61CA-4B91-8553-5C7DFEE6D12FQ35529674-64AEF71F-70A3-42E9-9547-42AED5948001Q35736596-00560A1A-F9C5-4B3B-871E-509A630BBD50Q36674612-89A7CFAA-0B85-4F7E-B683-79F37C6BAB5FQ36847209-E2E3C4B1-7AFC-4062-A33F-D364A30D9284Q37257611-81D51750-C8BC-49E5-A038-69BA56DC0F91Q37372349-697F4785-8138-4549-BEE9-A1DF8093CEAFQ37581801-7D077E30-F6F4-44F4-BE23-A15180239B92Q37598421-4C61FA46-1023-4428-9101-730062332C5EQ38174878-F6C924FA-6DCF-4BB4-8DAF-3C2460C51045Q38383566-9998F18E-907C-4A1E-BC5F-E4383E892CC7Q38665267-C56868BF-7FAA-4982-B54A-75F89B33C9CA
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Blood peptidome-degradome profile of breast cancer
@ast
Blood peptidome-degradome profile of breast cancer
@en
Blood peptidome-degradome profile of breast cancer
@nl
type
label
Blood peptidome-degradome profile of breast cancer
@ast
Blood peptidome-degradome profile of breast cancer
@en
Blood peptidome-degradome profile of breast cancer
@nl
prefLabel
Blood peptidome-degradome profile of breast cancer
@ast
Blood peptidome-degradome profile of breast cancer
@en
Blood peptidome-degradome profile of breast cancer
@nl
P2093
P2860
P50
P3181
P1433
P1476
Blood peptidome-degradome profile of breast cancer
@en
P2093
Brianne O Petritis
David G Camp
Marina A Gritsenko
Nikola Tolić
Ronald J Moore
Yufeng Shen
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0013133
P407
P577
2010-10-18T00:00:00Z